Cargando…

Optimal Anticoagulant Strategy for Periprocedural Management of Atrial Fibrillation Ablation: A Systematic Review and Network Meta-Analysis

This network meta-analysis was performed to rank the safety and efficacy of periprocedural anticoagulant strategies in patients undergoing atrial fibrillation ablation. MEDLINE, EMBASE, CENTRAL, and Web of Science were searched to identify randomized controlled trials comparing anticoagulant regimen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kino, Tabito, Kagimoto, Minako, Yamada, Takayuki, Ishii, Satoshi, Asai, Masanari, Asano, Shunichi, Yano, Hideto, Ishikawa, Toshiyuki, Ishigami, Tomoaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999346/ https://www.ncbi.nlm.nih.gov/pubmed/35407480 http://dx.doi.org/10.3390/jcm11071872

Ejemplares similares

Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation
por: van Vugt, S. P. G., et al.
Publicado: (2018)

Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
por: Maraj, Ilir, et al.
Publicado: (2018)

Report of periprocedural oral anticoagulants in catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF)
por: Murakawa, Yuji, et al.
Publicado: (2017)

Considerations Regarding the Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
por: Reiffel, James A.
Publicado: (2018)

Regulators of Epithelial Sodium Channels in Aldosterone-Sensitive Distal Nephrons (ASDN): Critical Roles of Nedd4L/Nedd4-2 and Salt-Sensitive Hypertension
por: Ishigami, Tomoaki, et al.
Publicado: (2020)

Outcomes of uninterrupted vs interrupted Periprocedural direct oral Anticoagulants in atrial Fibrillation ablation: A meta‐analysis
por: Basu‐Ray, Indranill, et al.
Publicado: (2021)

Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial
por: Hohnloser, Stefan H, et al.
Publicado: (2020)

Comparison of uninterrupted anticoagulation with dabigatran etexilate or warfarin in the periprocedural period for atrial fibrillation catheter ablation: Results of the Japanese subgroup of the RE‐CIRCUIT trial
por: Yoshida, Yukihiko, et al.
Publicado: (2018)

Hypnotic communication for periprocedural analgesia during transcatheter ablation of atrial fibrillation()
por: Scaglione, M., et al.
Publicado: (2019)

Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants
por: Brinkmeier-Theofanopoulou, Maria, et al.
Publicado: (2018)

Commensal Microbe-specific Activation of B2 Cell Subsets Contributes to Atherosclerosis Development Independently of Lipid Metabolism
por: Chen, Lin, et al.
Publicado: (2016)

Total Thrombus‐Formation Analysis System (T‐TAS) Can Predict Periprocedural Bleeding Events in Patients Undergoing Catheter Ablation for Atrial Fibrillation
por: Ito, Miwa, et al.
Publicado: (2016)

Uptake and Utilization of the Management of Anticoagulation in the Periprocedural Period App: Longitudinal Analysis
por: Spyropoulos, Alex C, et al.
Publicado: (2018)

Periprocedural anticoagulation in transcatheter aortic valve replacement: Heparin vs bivalirudin
por: Minhas, Abdul Mannan Khan, et al.
Publicado: (2017)

Outcomes in patients undergoing periprocedural interruption of warfarin or direct oral anticoagulants
por: Lee, Jeffrey, et al.
Publicado: (2022)

An isoform of Nedd4-2 is critically involved in the renal adaptation to high salt intake in mice
por: Minegishi, Shintaro, et al.
Publicado: (2016)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
por: Santangeli, Pasquale, et al.
Publicado: (2011)

Blood Pressure Elevation of Tubular Specific (P)RR Transgenic Mice and Lethal Tubular Degeneration due to Possible Intracellular Interactions between (P)RR and Alternative Renin Products
por: Saigo, Sae, et al.
Publicado: (2021)

Periprocedural Management of Direct Oral Anticoagulants Should Be Guided by Accurate Laboratory Tests
por: Lessire, Sarah, et al.
Publicado: (2016)

Periprocedural Management of Direct Oral Anticoagulants Surrounding Cardioversion and Invasive Electrophysiological Procedures
por: Finks, Shannon W., et al.
Publicado: (2018)

Association Between Periprocedural Heart Rate Trend and Postprocedural Worsening Heart Failure in Patients Receiving Catheter Ablation for Atrial Fibrillation
por: Kataoka, Naoya, et al.
Publicado: (2022)

The new era of atrial fibrillation treated by direct oral anticoagulants and catheter ablation—Comment on the “HAF‐NET Registry”
por: Yoshiga, Yasuhiro, et al.
Publicado: (2019)

Periprocedural anticoagulation in non-ST-segment elevation acute coronary syndrome: time to reassess?
por: Chandiramani, Rishi, et al.
Publicado: (2020)

Thromboembolic and bleeding risk of periprocedural bridging anticoagulation: A systematic review and meta‐analysis
por: Kuo, Hsien‐Cheng, et al.
Publicado: (2020)

Hyphema: A Rare Complication of Periprocedural Antiplatelets and Anticoagulants Following Percutaneous Coronary Intervention
por: Gulati, Amit, et al.
Publicado: (2021)

Eplerenone-Resistant Salt-Sensitive Hypertension in Nedd4-2 C2 KO Mice
por: Kino, Tabito, et al.
Publicado: (2017)

An Isoform of Nedd4-2 Plays a Pivotal Role in Electrophysiological Cardiac Abnormalities
por: Minegishi, Shintaro, et al.
Publicado: (2017)

Factors associated with bleeding events during catheter ablation with uninterrupted periprocedural edoxaban for atrial fibrillation: a subanalysis of the KYU-RABLE study
por: Abe, Ichitaro, et al.
Publicado: (2021)

Association Between Periprocedural Heart Rate Trend and Postprocedural Worsening Heart Failure in Patients Receiving Catheter Ablation for Atrial Fibrillation　― Reply ―
por: Matsuda, Yasuhiro, et al.
Publicado: (2022)

The Regulatory Role of T Cell Responses in Cardiac Remodeling Following Myocardial Infarction
por: Kino, Tabito, et al.
Publicado: (2020)

Simple periprocedural precautions to reduce Doppler microembolic signals during AF ablation
por: Christoph, Marian, et al.
Publicado: (2021)

Periprocedural heparin bridging in patients receiving oral anticoagulation: a systematic review and meta-analysis
por: Yong, Jing Wen, et al.
Publicado: (2017)

Periprocedural Direct Oral Anticoagulant Management: The RA-ACOD Prospective, Multicenter Real-World Registry
por: Ferrandis, Raquel, et al.
Publicado: (2020)

Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa)
por: Hatori, Yutaka, et al.
Publicado: (2017)

Periprocedural complications and one-year outcomes after catheter ablation for treatment of atrial fibrillation in elderly patients: a nationwide Danish cohort study
por: Nielsen, Jesper, et al.
Publicado: (2021)

Association between red blood cell parameters & atrial fibrillation after acute myocardial infarction
por: Kotani, Kazuhiko, et al.
Publicado: (2015)

Analgesic effects of dexmedetomidine and remifentanil on periprocedural pain during percutaneous ablation of renal carcinoma
por: Semenas, Egidijus, et al.
Publicado: (2020)

Safety and Efficacy of Underdosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation
por: Yamaji, Hirosuke, et al.
Publicado: (2017)

Knots to untie: anticoagulant and antiarrhythmic therapy after ablation for atrial fibrillation
por: Stazi, Filippo
Publicado: (2020)

Effects of uninterrupted dabigatran on the intensity of anticoagulation during atrial fibrillation ablation
por: Osawa, Takumi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8s2b8kbrr7eoals7eaee7h80qd